Potential therapeutic implications of new insights into respiratory syncytial virus disease

Respiratory Research

Volumn 3, Issue , 2002, Pages

  Openshaw, Peter J M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Antiviral agents; Asthma; Bronchiolitis; Respiratory syncytial virus

Indexed keywords

DNA VACCINE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; RESPIRATORY SYNCYTIAL VIRUS VACCINE; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ARTICLE; ASTHMA; CELL ACTIVATION; CHEMOTAXIS; CHILD HOSPITALIZATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHIL; HELPER CELL; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLAMMATORY CELL; MACROPHAGE; MORBIDITY; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN SUBUNIT; RESPIRATORY SYNCYTIAL VIRUS INFECTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRAL BRONCHIOLITIS; VIRUS TRANSMISSION; WHEEZING; ANIMAL; ANTIBODY PRODUCTION; IMMUNOLOGY; REVIEW; VIRUS INFECTION;

ANIMALS; ANTIBODY FORMATION; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 0003150904     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/rr184     Document Type: Article

References (45)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999, 282:1440-1446.
2. Anderson LJ, Heilman CA: Protective and disease-enhancing immune responses to respiratory syncytial virus. J Infect Dis 1995, 171:1-7.
3. Parrott RH, Kim HW, Arrobio JO, Hodes DS, Murphy BR, Brandt CD, Camargo E, Chanock RM: Epidemiology of respiratory syncytial virus infection in Washington, D.C.: II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 1973, 98:289-300.
4. Openshaw PJ, Hewitt C: Protective and harmful effects of viral infections in childhood on wheezing disorders and asthma. Am J Respir Crit Care Med 2000, 162:S40-S43.
5. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000, 161:1501-1507.
6. O'Donnell DR, Openshaw PJ: Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clin Exp Allergy 1998, 28:1501-1508.
7. Valarcher JF, Bourhy H, Lavenu A, Bourges-Abella N, Roth M, Andreoletti O, Ave P, Schelcher F: Persistent infection of B lymphocytes by bovine respiratory syncytial virus. Virology 2001, 291:55-67.
8. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, Becker S: Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995, 171:584-592.
9. Einarsson O, Geba GP, Zhu Z, Landry M, Elias JA: Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996, 97:915-924.
10. Calhoun WJ, Swenson CA, Dick EC, Schwartz LB, Lemanske RF Jr, Busse WW: Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1991, 144:1267-1273.
11. Everard ML, Swarbrick A, Wrightham M, McIntyre J, Dunkley C, James PD, Sewell HF, Milner AD: Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994, 71:428-432.
12. Teran LM, Seminario MC, Shute JK, Papi A, Compton SJ, Low JL, Gleich GJ, Johnston SL: RANTES, macrophage-inhibitory protein 1alpha, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children. J Infect Dis 1999, 179:677-681.
13. Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB: Respiratory syncytial virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med 1999, 159:1918-1924.
14. Isaacs D, Bangham CRM, McMichael AJ: Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 1987, 2:769-771.
15. Welliver RC: Immunologic mechanisms of virus-induced wheezing and asthma. J Pediatr 1999, 135:14-20.
16. Romagnani S: Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today 1992, 13:379-381.
17. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE: Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998, 157:1708-1720.
18. Openshaw PJM, Pala P, Sparer T, Matthews S, Pennycook A, Hussell T: T-cell subsets and lung inflammation: lessons from respiratory syncytial virus. Eur Respir Rev 2000, 10:108-111.
19. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL: Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981, 98:708-715.
20. Kaul TN, Faden H, Ogra PL: Effect of respiratory syncytial virus and virus-antibody complexes on the oxidative metabolism of human neutrophils. Infect Immun 1981, 32:649-654.
21. Nadal D, Ogra PL: Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections. Lung 1990,168(suppl):379-387.
22. Welliver RC, Kaul TN, Ogra PL: The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med 1980, 303:1198-1202.
23. Openshaw PJ: Potential mechanisms causing delayed effects of respiratory syncytial virus infection. Am J Respir Crit Care Med 2001, 163:S10-S13.
24. Lemanske RF Jr: Immunologic mechanisms in RSV-related allergy and asthma. In RSV and Asthma: Is There a Link?. (Edited by: Hiatt PW). New York: American Thoracic Society 1998, 11-16.
25. Openshaw PJM, Matthews S, Pala P, Hussell T, Walzl G: Immunopathogenesis of viral infections in children. In Textbook of Respiratory Cell and Molecular Biology. (Edited by: Wardlaw AJ, Hamid QA). London: Martin Dunitz Ltd 2002, 283-298.
26. Alwan WH, Kozlowska WJ, Openshaw PJM: Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med 1994, 179:81-89.
27. Hussell T, Georgiou A, Sparer TE, Matthews S, Pala P, Openshaw PJM: Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. J Immunol 1998, 161:6215-6222.
28. Smyth RL, Fletcher JN, Thomas HM, Hart CA, Openshaw PJM: Respiratory syncytial virus and wheeze. Lancet 1999, 354:1997-1998.
29. McConnochie KM, Roghmann KJ: Wheezing at 8 and 13 years: changing importance of bronchiolitis and passive smoking. Pediatr Pulmonol 1989, 6:138-146.
30. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD: Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999, 354:541-545.
31. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B: Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995, 95:500-505.
32. Noble V, Murray M, Webb MSC, Alexander J, Swarbrick AS, Milner AD: Respiratory status and allergy nine to 10 years after acute bronchiolitis. Arch Dis Child 1997, 76:315-319.
33. Welliver RC, Duffy L: The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 1993, 15:19-27.
34. Ehlenfield DR, Cameron K, Welliver RC: Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 2000, 105:79-83.
35. Pala P, Bjarnason R, Sigurbergsson F, Metcalfe C, Sigurs N, Openshaw PJM: Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy. Eur Respir J 2002, in press.
36. Teran LM, Johnston SL, Schroder JM, Church MK, Holgate ST: Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997, 155:1362-1366.
37. Robinson PJ, Hegele RG, Schellenberg RR: Allergic sensitization increases airway reactivity in guinea pigs with respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 1997, 100:492-498.
38. Kumar A, Sorkness RL, Kaplan MR, Lemanske RF Jr: Chronic, episodic, reversible airway obstruction after viral bronchiolitis in rats. Am J Respir Crit Care Med 1997, 155:130-134.
39. Dakhama A, Vitalis TZ, Hegele RG: Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis. Eur Respir J 1997, 10:20-26.
40. Long CE, McBride JT, Hall CB: Sequelae of respiratory syncytial virus infections. A role for intervention studies. Am J Respir Crit Care Med 1995, 151:1678-1681.
41. Balfour-Lynn IM, Openshaw PJM: Viral infection. In Childhood Asthma and Other Wheezing Disorders. (Edited by: Silverman M). London: Edward Arnold 2002, in press.
42. Dudas RA, Karron RA: Respiratory syncytial virus vaccines. Clin Microbiol Rev 1998, 11:430-439.
43. Crowe JE Jr: Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Vaccine 1998, 16:1423-1432.
44. Olszewska W, Zambon M, Openshaw PJM: Vaccination against common colds. Br Med Bull 2002, 62:99-111.
45. Englund J, Glezen WP, Piedra PA: Maternal immunization against viral disease. Vaccine 1998, 16:1456-1463.